Evidence map›Paper›PMID 34181348›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2021

Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians.

Kyriakos Souliotis, Lily E Peppou, Marina Economou, Androniki Marioli, Sofia Nikolaidi, Maria Saridi, Dimitrios Varvaras, Antonia Paschali, Konstantinos N Syrigos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kyriakos SouliotisFaculty of Social & Political Sciences, University of Peloponnese, Corinth, Greece.ORCID 0000-0003-1624-9444
Lily E PeppouSchool of Nursing, University of Thessaly Greece.
Marina EconomouCommunity Mental Health Centre, University Mental Health Research Institute (UMHRI), Athens, Greece.
Androniki MarioliDivision of Medical Oncology, Third Department of Medicine, Kapodistrian University of Athens, Athens, Greece.
Sofia NikolaidiHealth Policy Institute (HPI), Athens, Greece.
Maria SaridiSchool of Nursing, University of Thessaly Greece.ORCID 0000-0002-9008-824X
Dimitrios VarvarasSurgical Oncology Unit, Nuova Villa Claudia, Rome, Italy.ORCID 0000-0002-0614-0392
Antonia PaschaliFaculty of Nursing, School of Health Sciences, Department of Mental Health and Behavioral Sciences, Kapodistrian University of Athens, Athens, Greece.
Konstantinos N SyrigosDivision of Medical Oncology, Third Department of Medicine, Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0001-5335-8346

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdherence to treatment can be defined as the degree to which a patient's behavior is consonant with medical or health advice he or she receive as part of his treatment regimen. The aim of this study was:  1) to measure the rate of treatment adherence to among patients with lung cancer from the prospect of both patients and physicians, 2) to measure the degree of concordance between the two prospect, and 3) to identify factors related to adherence for both prospect (patients and physicians). MATERIALS AND

methodsA total of 250 patients were included in this study. Information about socio-economic characteristics, depressive and anxiety symptoms (Hospital Anxiety and Depression scale), nicotine dependence (Fagerstrom scale), barriers to accessing care, and the level of treatment adherence was collected through interview. Physicians were enquired about disease and treatment variables as well as patients' level of adherence.

resultsFrom the patient perspective, only 1.2% of patients displayed poor adherence; whereas the corresponding percentage among physicians was 12.4%. The concordance between the two was low: 0.244. The correlation of measurements made on the same individual was found to be equal to 0.14. Barriers to accessing medication (O.R.=2.82, 95% C.I.: 1.01-8.09) was the only risk factor when adherence was self-rated; barriers to accessing medication (O.R.=2.45, 95% C.I.: 1.03-5.86), education equal to 12 years (O.R.=0.33, 95% C.I.: 0.13-0.82) or higher than 12 years (O.R.=0.28, 95% C.I.: 0.08-0.96), nicotine dependence (O.R.=1.41, 95% C.I. 1.17-1.69) and HADS anxiety score (O.R.=1.15, 95% C.I. 1.03-1.30) were the predictors in physicians' rating.

conclusionsDifferences in rating adherence may underpin communication gaps between patients and physicians. Systemic determinants of poor adherence should not be overlooked. A concerted effort by researchers, physicians and policy makers in defining as well as communicating adherence, while removing its barriers should be made.<br />.

Indexed as

Attitude of Health PersonnelPhysician-Patient RelationsAgedAnxietyDepressionEducational StatusFemaleGreeceHumansLung NeoplasmsMaleNeoplasm StagingRisk FactorsTreatment Adherence and ComplianceAnxietyBarriersdepressionnicotine dependenceOncology

Identifiers

PMID34181348
PMCPMC8418830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.